Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit
The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit, a targeted, next-generation sequencing panel for the detection of clinically relevant variants across a multitude of tumor types, including non-small cell lung cancer, colorectal cancer, and melanoma.
The ACMG Annual Clinical Genetics Meeting provides genetics professionals with a high caliber scientific program that presents the latest developments and research in clinical genetics and genomics. Come visit us at Booth 828 to learn more about our robust genetic portfolio!
Learn more about what we have planned at the conference: asuragen.com/acmg19
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.